Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Pat Ansell a Leukaemia Research Fund Centre, Institute of
Epidemiology, University of Leeds, Leeds LS2 9LN, b Mother and
Infant Research Unit, University of Leeds, Leeds LS2 9LN
Correspondence to: P Ansell p.e.ansell{at}leeds.ac.uk
Objectives:
To investigate policies on neonatal
vitamin K and their implementation.
What is already known on this topic
What this study adds
Design:
Two phase postal survey.
Setting:
United Kingdom.
Participants:
A 10% random sample of midwives
registered with the United Kingdom Central Council for nursing,
midwifery, and health visiting. Of 3191 midwives in the sample, 2515 (79%) responded to phase one and 2294 (72%) completed questionnaires on their current jobs (November 1998 to May 1999). In phase two, 853 (62%) of 1383 eligible midwives gave details on 2179 of their earliest
jobs (start dates before 1990).
Results:
All the midwives in clinical practice at the time of the survey (2271, 99%) reported that they were working in
areas with official policies on neonatal vitamin K. Seven distinct policies were described: intramuscular vitamin K for all babies (1159, 51.0%); intramuscular vitamin K for babies at "high risk," oral
for others (470, 20.7%); oral vitamin K for all babies (323, 14.2%);
parental choice for all (124, 5.5%); parental choice for all except
babies at high risk, (119, 5.2%); intramuscular vitamin K for babies
at high risk only (33, 1.5%); oral vitamin K for babies at high risk
only (17, 0.7%); and a disparate group of policies including
intravenous vitamin K for some babies (26, 1.1%). Previous policies
were (and some may still be) open to individual interpretation and were
not always followed.
Conclusions:
Hospital policy is not necessarily a
good guide to individual practice. The primary purpose of clinical records is to document patient care, and recording practices reflect this. There is considerable variation in vitamin K policies and midwifery practice in the United Kingdom, and there is no clear consensus on which babies should receive vitamin K intramuscularly.
Neonatal administration of vitamin K by the intramuscular route
is effective in the prevention of haemorrhagic disease in newborn
babies but has been suggested as a possible risk factor for leukaemia
in children
Earlier hospital policies were open to individual interpretation and
they were not always followed
Read all Rapid Responses